[go: up one dir, main page]

CN1056087C - Method for preparation of biofunctional medical adhesive-bonded fabric dressing and its products - Google Patents

Method for preparation of biofunctional medical adhesive-bonded fabric dressing and its products Download PDF

Info

Publication number
CN1056087C
CN1056087C CN95108238A CN95108238A CN1056087C CN 1056087 C CN1056087 C CN 1056087C CN 95108238 A CN95108238 A CN 95108238A CN 95108238 A CN95108238 A CN 95108238A CN 1056087 C CN1056087 C CN 1056087C
Authority
CN
China
Prior art keywords
alginate
chitosan
woven cloth
short fiber
dressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95108238A
Other languages
Chinese (zh)
Other versions
CN1119547A (en
Inventor
孙玉山
刘洪斌
骆强
王玥
李振华
刘志国
陆伊纶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Textile Academy
Original Assignee
China Textile Academy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Textile Academy filed Critical China Textile Academy
Priority to CN95108238A priority Critical patent/CN1056087C/en
Publication of CN1119547A publication Critical patent/CN1119547A/en
Application granted granted Critical
Publication of CN1056087C publication Critical patent/CN1056087C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

本发明涉及生体功能性医用无纺布敷料的制造方法及其制品。本发明将甲壳胺-藻朊酸盐混合纤维预刺无纺布作为底层,以藻朊酸盐或其它吸水性纤维的预刺无纺布作为上层,在主针刺机上经双层复合针刺制成。本发明医用无纺布的制法工艺简便,成品率高,加工成本低。本发明制品广谱抑菌,促进愈合,减少疤痕,止血,综合甲壳胺和藻朊酸盐的多种生物功能。The invention relates to a manufacturing method of a biofunctional medical non-woven dressing and products thereof. In the present invention, the chitosan-alginate mixed fiber pre-punched non-woven fabric is used as the bottom layer, and the pre-punched non-woven fabric of alginate or other water-absorbing fibers is used as the upper layer. production. The preparation method of the medical non-woven fabric of the invention is simple and convenient, the yield is high, and the processing cost is low. The product of the invention has broad-spectrum antibacterial, promotes healing, reduces scars, stops bleeding, and integrates multiple biological functions of chitosan and alginate.

Description

生体功能性医用无纺布敷料的制造方法及其制品Production method and product of biofunctional medical non-woven dressing

本发明涉及创伤用敷料领域,特别涉及生体功能性医用无纺布敷料的制法及其制品。The invention relates to the field of wound dressings, in particular to a method for preparing biofunctional medical non-woven dressings and products thereof.

WO89/12471公开了制藻朊酸钙纤维无纺布的方法,该法通过湿法纺丝工艺制得藻朊酸钙纤维,然后通过后处理工艺调节藻朊酸盐中的钙/纳比以得到适于医用止血敷料用途的藻朊酸钙/纳盐纤维,其中,纳盐含量决定了形成止血凝胶层的能力,钙离子起凝血酶作用,这种无纺布敷料后处理工艺繁复,成本较高。WO89/12471 discloses the method for making calcium alginate fiber non-woven fabric, this method makes calcium alginate fiber by wet spinning process, then adjusts the calcium/na ratio in alginate by post-treatment process to obtain Calcium alginate/sodium salt fibers suitable for medical hemostatic dressings are obtained, wherein the content of sodium salts determines the ability to form a hemostatic gel layer, and calcium ions act as thrombin. The post-treatment process of this non-woven dressing is complicated, higher cost.

EP0171254公开了将几丁质纤维进行脱乙酰化,即高温碱处理后与聚乙烯醇纤维混合抄纸,或织成布后脱乙酰化作用作为具有促愈作用的医用敷料的方法,其中,脱乙酰化生成的-NH2基因具有较高的生物活性和形成凝胶的能力。特开昭62-170254则是将甲壳胺纤维进行部分恢复乙酰基处理,即以含甲醇等的无水醋酸浸渍,然后与聚乙烯醇纤维混合抄纸或织成布以改善耐水性。这两种方法的加工成本都很高,在止血效果方面不理想。EP0171254 discloses deacetylation of chitin fibers, that is, after high-temperature alkali treatment, mixing with polyvinyl alcohol fibers to make paper, or deacetylation after weaving into cloth as a medical dressing with a healing effect. The -NH 2 gene produced by acetylation has higher biological activity and gel-forming ability. In Japanese Patent Application No. 62-170254, chitosan fibers are partially restored to acetylation, that is, they are impregnated with anhydrous acetic acid containing methanol, etc., and then mixed with polyvinyl alcohol fibers to make paper or weave them into cloth to improve water resistance. The processing cost of these two methods is very high, and the hemostatic effect is not ideal.

CN1067279A公开了一种以几丁质纤维和藻朊酸盐纤维混合抄纸制备生体功能性医用无纺布的方法及其制品。但几丁质纤维形成凝胶的能力较差,且加工成本远远高于甲壳胺纤维和藻朊酸盐纤维,所得纸状湿法无纺布的膨松柔软性、赋形和保形性能较差。CN1067279A discloses a method for preparing biofunctional medical non-woven fabric by mixing chitin fiber and alginate fiber for papermaking and its products. However, the ability of chitin fibers to form gels is poor, and the processing cost is much higher than that of chitosan fibers and alginate fibers. poor.

本发明的目的在于:提供一种生体功能性医用无纺布敷料的制法及其制品。这种无纺布膨松柔软性和透气性好,赋形和保形性好,保温保湿性能强,生体适应性能优异并兼具止血、促愈、减少疤痕的作用,制法工艺简便、合理、成本低。The object of the present invention is to provide a method for preparing biofunctional medical non-woven dressing and its products. This kind of non-woven fabric has good bulkiness, softness and air permeability, good shape-forming and shape-retaining properties, strong heat preservation and moisturizing performance, excellent bio-adaptability and the functions of stopping bleeding, promoting healing and reducing scars. The preparation method is simple and reasonable. ,low cost.

本发明的目的是这样达成的:提供一种生体功能医用无纺布敷料的制造方法,所述方法包括如下步骤:The purpose of the present invention is achieved like this: provide a kind of manufacture method of biological function medical non-woven dressing, described method comprises the steps:

a)将甲壳胺短纤维和其中钠离子和钙离子重量比为10∶90-30∶70的藻朊酸盐短纤维混合;a) mixing chitosan short fibers with alginate short fibers wherein the weight ratio of sodium ions and calcium ions is 10:90-30:70;

b)将a)步骤所得混合纤维经梳理机梳理成网,再经铺网,预针剌,得到甲壳胺-藻朊酸盐混合纤维预剌无纺布;b) combing the mixed fiber obtained in step a) into a net through a carding machine, then laying the net, and pre-punching to obtain a pre-punched non-woven fabric of chitosan-alginate mixed fiber;

c)将其中钠离子和钙离子重量比为10∶90-30∶70的藻朊酸盐短纤维或其它吸水性纤维经梳理机梳理成网,再经铺网,预针剌,得到单一的藻朊酸盐纤维或其它吸水性纤维的预剌无纺布;c) Carding alginate short fibers or other water-absorbing fibers in which the weight ratio of sodium ions to calcium ions is 10:90-30:70 is carded into a web, and then the web is laid and pre-acupunctured to obtain a single Prepunched nonwovens of alginate fibers or other absorbent fibers;

d)以b)步骤所制甲壳胺-藻朊酸盐混合纤维预剌无纺布为底层,以c)步骤所制单一的藻朊酸盐或其它吸水性纤维的预剌无纺布为上层,在主针剌机上经双层复合针剌,得到生体功能性医用无纺布敷料。d) The chitosan-alginate mixed fiber pre-spun non-woven fabric made in step b) is the bottom layer, and the single alginate or other water-absorbent fiber pre-punched non-woven fabric made in c) step is the upper layer , on the main acupuncture machine through double-layer composite acupuncture, to obtain biofunctional medical non-woven dressings.

在a)步骤中的甲壳胺短纤维和藻朊酸盐短纤维的混合比例是:甲壳胺短纤维占甲壳胺短纤维和藻朊酸盐短纤维总重量的5%-100%。在c)步骤中所述其它吸水性纤维是棉纤维,维尼纶纤维或粘胶纤维。在a)步骤中所述生体功能性医用无纺布敷料中,作为甲壳胺-藻朊酸盐混合纤维无纺布的单位面积重量是20-200克/平方米;作为上层的单一藻朊酸盐或者它的吸水性纤维预剌无纺布的单位面积重量是40-400克/平方米。The mixing ratio of chitosan short fibers and alginate short fibers in the step a) is: chitosan short fibers account for 5%-100% of the total weight of chitosan short fibers and alginate short fibers. The other water-absorbent fibers in step c) are cotton fibers, vinylon fibers or viscose fibers. In the biofunctional medical nonwoven dressing described in a) step, the weight per unit area as the chitosan-alginate mixed fiber nonwoven fabric is 20-200 g/square meter; the single alginic acid as the upper layer The weight per unit area of salt or its water-absorbent fiber prepunched nonwoven fabric is 40-400 grams per square meter.

本发明另一目的是这样达成的,提供一种生体功能医用无纺布敷料制品,所述制品是以甲壳胺短纤维和其中钠离子和钙离子重量比为10∶90-30∶70的藻朊酸盐短纤维混合后经梳理成网、铺网和预针剌的甲壳胺-藻朊酸盐混合纤维的预剌无纱布作为底层,以其中钠离子和钙离子重量比为10∶90-30∶70的藻朊酸盐短纤维或其它吸水性纤维经梳理成网、铺网和预针剌的单一藻朊酸盐或其它吸水性纤维的预剌无纺布作为上层的双层复合针剌无纺布敷料。甲壳胺-藻朊酸盐混合纤维的预制无纺布中甲壳胺短纤维和藻朊酸盐短纤维的混合比例是:甲壳胺短纤维占甲壳胺短纤维和藻朊酸盐短纤维总重量的5-100%。作为上层的其它吸水性纤维预剌无纺布中的其它吸水性纤维是棉纤维、维尼纶纤维或粘胶纤维。作为底层的甲壳胺-藻朊酸盐混合纤维预剌无纺布的单位面积重量是20-200克/平方米;作为上层的单-藻朊酸盐或其它吸水性纤维预剌无纺布的单位面积重量是40-400克/平方米。Another object of the present invention is achieved by providing a biofunctional medical non-woven dressing product. After the prionate short fibers are mixed, the pre-punched non-gauze cloth of the chitosan-alginate mixed fiber is carded, laid and pre-needled as the bottom layer, and the weight ratio of sodium ions and calcium ions is 10:90- 30:70 alginate staple fiber or other water-absorbing fiber carded, laid and pre-needled single alginate or other water-absorbing fiber pre-punched non-woven fabric as the upper double-layer composite needle Thorn non-woven dressing. The mixing ratio of chitosan short fibers and alginate short fibers in the prefabricated non-woven fabric of chitosan-alginate mixed fibers is: chitosan short fibers account for the total weight of chitosan short fibers and alginate short fibers 5-100%. Other water-absorbent fibers as upper layer The other water-absorbent fibers in the prepunched nonwoven are cotton fibers, vinylon fibers or viscose fibers. The weight per unit area of the chitosan-alginate mixed fiber prepunched nonwoven fabric as the bottom layer is 20-200 g/m2; The weight per unit area is 40-400 grams per square meter.

以下结合实施例对本发明进行详细说明。The present invention will be described in detail below in conjunction with the examples.

甲壳胺是一种胺基葡萄糖构成的生物高分子,是由存在于虾皮、蟹壳、蚕蛹皮等物质中的乙酰氨基葡萄糖经脱乙酰化而得到。现代医学研究表明,它具有广谱抑菌、抑制成纤维生长、促进表皮细胞生长的功能,因而可以起到防止感染、减少疤痕的作用,其中钠离子和钙离子重量比为10∶90-30∶70的藻朊酸盐是由棕海带中提取的有效成分,是由甘露糖醛酸和古洛糖酸构成的生物高分子盐,富含作为主要凝血因子的活性钙成份,因而具有优异的止血作用,以上两种生物高分子均具有高吸液性、生物相容性和生物降解可吸收性。本发明中选用了甲壳胺纤维与藻朊酸纤维混合加工成无纺布,主要考虑以下几点:Chitosan is a biopolymer composed of glucosamine, which is obtained by deacetylation of acetylglucosamine present in shrimp skin, crab shell, silkworm chrysalis skin and other substances. Modern medical research shows that it has the functions of broad-spectrum antibacterial, inhibiting fibroblast growth, and promoting the growth of epidermal cells, so it can prevent infection and reduce scars. The weight ratio of sodium ions to calcium ions is 10:90-30 :70 alginate is an active ingredient extracted from brown kelp, a biopolymer salt composed of mannuronic acid and gulonic acid, rich in active calcium as the main blood coagulation factor, and thus has excellent For hemostasis, the above two biopolymers have high liquid absorption, biocompatibility and biodegradable absorbability. In the present invention, selected chitosan fiber and alginic acid fiber are mixed and processed into non-woven fabric, mainly considering the following points:

1)它比几丁质纤维成本低(比藻朊酸盐纤维高);1) It is less costly than chitin fiber (higher than alginate fiber);

2)它比几丁纤维形成凝胶的能力强,与藻朊酸盐中的活性钙凝血因子一同起物理止血和生物化学止血双重作用,从而由湿法纺丝得到的藻朊酸钙纤维可以无须再进行调节钙/钠比以控制凝胶形成能力的后加工处理;2) It has a stronger ability to form a gel than chitin fibers, and plays a dual role in physical hemostasis and biochemical hemostasis together with the active calcium coagulation factor in alginate, so that the calcium alginate fiber obtained by wet spinning can There is no need for post-processing to adjust the calcium/sodium ratio to control the gel forming ability;

3)它具有广谱抑菌,促进愈合、减少疤痕的作用。3) It has a broad-spectrum antibacterial effect, promotes healing and reduces scars.

实施例1Example 1

将蟹壳洗涤、干燥后粉碎经过每6.5平方厘米有50孔的筛网,在7.4%盐溶液中10℃下脱钙30分钟,水洗后在4%NaOH溶液中85℃下脱蛋白质3小时,水洗至中性得几丁质,将几丁质在50%的NaOH溶液中100℃下处理4小时后,用盐酸中和,反复清洗,干燥后得到甲壳胺。在25℃把甲壳胺溶解到5%(体积百分数)的醋酸溶液中,得到7%的纺丝原液,该原液经过滤,脱泡后以孔径为0.08mm、孔数为2000孔的喷丝板挤出到10%NaOH水溶液中,丝束以6米/分的速度导出后牵伸1.4倍,经充分水洗干燥得到单丝纤度1.5d,强度2.5g/d的甲壳胺纤维。将藻朊酸钠溶于水配成7%的纺丝原液,经过滤脱泡后以孔径为0.10mm、孔数为10000孔的喷丝板挤出到含0.7%氯化钙的凝固浴中固化成形,丝束以10米/分的速度导出后牵伸2.0倍,得到单丝纤度1.5d、强度2.9g/d、其中钠离子与钙离子的重量比例为50∶50的藻朊酸盐纤维。将两种纤维切断成60毫米长的短纤后,在梳理机上以50/50比例混合梳理成网,经铺网、预针剌得到单位面积重量为30克/米2的混合纤维予剌无纺布。以单一藻朊酸盐为原料,经同样加工工序,制得单位面积重量为70克/米2的藻朊酸盐纤维预剌无纺布。以混合材料无纺布为底层,以单一材料无纺布为上层,在主针剌机上经双层复合针剌后制行所述生体功能性医用无纺布敷料。该医用无纺布敷料的制法及制品完全达到本发明目的。Crab shells were washed and dried and crushed through a sieve with 50 holes per 6.5 square centimeters, decalcified in 7.4% salt solution at 10°C for 30 minutes, washed with water and deproteinized in 4% NaOH solution at 85°C for 3 hours, Chitin was obtained by washing with water until it became neutral. After treating chitin in 50% NaOH solution at 100°C for 4 hours, it was neutralized with hydrochloric acid, washed repeatedly, and dried to obtain chitosan. Dissolve chitosan in 5% (volume percent) acetic acid solution at 25°C to obtain 7% spinning stock solution, which is filtered and defoamed with a spinneret with a pore size of 0.08 mm and a hole number of 2000 holes Extruded into a 10% NaOH aqueous solution, the tow was drawn out at a speed of 6 m/min, drawn 1.4 times, and fully washed and dried to obtain a chitosan fiber with a monofilament fineness of 1.5d and a strength of 2.5g/d. Dissolve sodium alginate in water to make 7% spinning stock solution, and extrude it into a coagulation bath containing 0.7% calcium chloride through a spinneret with a hole diameter of 0.10 mm and a hole number of 10,000 holes after filtration and defoaming After solidification and forming, the tow is drawn out at a speed of 10 m/min and drawn 2.0 times to obtain an alginate with a single filament fineness of 1.5d, a strength of 2.9g/d, and a weight ratio of sodium ions to calcium ions of 50:50. fiber. After the two kinds of fibers are cut into short fibers of 60 mm length, they are mixed and carded into a net at a ratio of 50/50 on a carding machine, and the mixed fibers with a unit area weight of 30 g/m are obtained through laying and pre-needling. spinning. Using a single alginate as a raw material, through the same processing procedure, a prepunched non-woven fabric of alginate fiber with a unit area weight of 70 g/ m2 was obtained. The non-woven fabric with mixed material is used as the bottom layer, and the non-woven fabric with single material is used as the upper layer, and the biofunctional medical non-woven fabric dressing is produced after double-layer composite needle punching on the main needle punching machine. The preparation method and the goods of this medical non-woven dressing fully reach the object of the present invention.

实施例2Example 2

以实施例1所述混合纤维预剌无纺布为底层,以单位面积重量为150克/米2的棉纤维无纺布为上层,在主针剌机上经双层复合针剌后制得所述生体功能性无纺布医用敷料。这种无纺布适合于临床上体表用途,成本较低。The mixed fiber prepunched non-woven fabric described in Example 1 is the bottom layer, and the cotton fiber non-woven fabric with a weight per unit area of 150 g/ m is the upper layer, and the obtained product is obtained after double-layer composite needle punching on the main needle punching machine. Describe biofunctional non-woven medical dressings. This non-woven fabric is suitable for clinical use on the body surface, and the cost is relatively low.

实施例3Example 3

以实施例1所述的甲壳胺短纤维在梳理机上梳理成网,经铺网、预针剌得到以单一甲壳胺纤维为原料的单位面积重量为50克/米2预针剌无纺布;以单一藻朊酸盐为原料,经同样加工工序,制得单位面积重量为70克/米2的藻朊酸盐纤维预剌无纺布以单一甲壳胺纤维预针剌无纺布为底层,以单一藻朊酸盐纤维预剌无纺布为上层,在主针剌机上经过双层复合针剌后制得所述生体功性无纺布医用敷料。所制得的制品同样达到本发明目的。With the chitosan staple fiber described in embodiment 1 carded into a net on a carding machine, the weight per unit area obtained with a single chitosan fiber as a raw material is 50 g/ m Pre-needled non-woven fabric through laying and pre-needling; Using a single alginate as a raw material, through the same processing procedure, a pre-punched non-woven fabric of alginate fiber with a weight per unit area of 70 g/ m2 is obtained. The pre-punched non-woven fabric of a single chitosan fiber is used as the bottom layer. The biofunctional nonwoven medical dressing is prepared by using a single alginate fiber prepunched non-woven fabric as an upper layer, and after double-layer composite needle punching on a main needle punching machine. The prepared product also achieves the object of the present invention.

本发明具有良好的效果。本发明所用的甲壳-藻朊酸盐混合纤维制成的干法针剌无纺布与湿法抄纸所得无纺布相比,具有膨松柔松和透气性好、赋形和保形性能强的优点;与织布工艺相比,工艺简便,成品率高,成本降低,本发明生体功能性医用无纺布敷料制品同时综合甲壳胺和藻朊酸盐的多种功能并加强止血功能,兼具广谱抑菌性,促愈合,减少疤痕,具有高吸液性,生物相容性和生物降解可吸收性,并具有优良的赋形性和保形性能。The present invention has good effects. Compared with the non-woven fabric obtained by wet papermaking, the dry-laid needle-punched non-woven fabric made of the carapace-alginate mixed fiber used in the present invention has bulkiness, softness, good air permeability, shape-shaping and shape-retaining properties Strong advantages; compared with the weaving process, the process is simple, the yield is high, and the cost is reduced. The biofunctional medical non-woven dressing product of the present invention simultaneously integrates multiple functions of chitosan and alginate and strengthens the hemostatic function. It has broad-spectrum antibacterial properties, promotes healing, reduces scars, has high liquid absorption, biocompatibility and biodegradable absorbability, and has excellent shape-forming and shape-retaining properties.

Claims (8)

1, the manufacture method of medical non-woven cloth with organism function dressing is characterized in that having the following steps:
A) with the chitosan short fiber and wherein sodium ion and calcium ion weight ratio be 10: 90-30: 70 alginate short fiber mixes;
B) with a) step gained composite fibre through the carding machine carding, again through lapping, pre-pin is perverse, obtains chitosan-pre-needled non-woven cloth of alginate composite fibre;
C) wherein sodium ion and calcium ion weight ratio are 10: 90-30: 70 alginate short fiber or other hygroscopicity fibre are through the carding machine carding, again through lapping, pre-pin is perverse, obtains the pre-needled non-woven cloth of single alginate fiber or other hygroscopicity fibre;
D) with b) the made chitosan of step-pre-needled non-woven cloth of alginate composite fibre is bottom, with c) the pre-needled non-woven cloth of the made single alginate of step or other hygroscopicity fibre is the upper strata, perverse through the two-layer compound pin on the perverse machine of main pin, obtain medical non-woven cloth with organism function dressing.
2, according to the manufacture method of the described living body function medical adhesive-bonded fabric dressing of claim 1, it is characterized in that: the chitosan short fiber in a) step and the mixed proportion of alginate short fiber are: the chitosan short fiber accounts for the 5%-100% of chitosan short fiber and alginate short fiber gross weight.
3, according to the manufacture method of the described medical non-woven cloth with organism function dressing of claim 1, it is characterized in that: at c) other hygroscopicity fibre described in the step is cotton fiber, vinylon fiber or viscose rayon.
4, according to the manufacture method of each described medical non-woven cloth with organism function dressing of claim 1-3, it is characterized in that: in a) dressing of medical non-woven cloth with organism function described in the step, as the weight per unit area of chitosan-alginate composite fibre non-woven fabrics be the 20-200 gram/square metre; As the weight per unit area of the single alginate on upper strata or its pre-needled non-woven cloth of hygroscopicity fibre be the 40-400 gram/square metre.
5, the medical non-woven cloth with organism function dressing procucts is characterized in that: described goods be with the chitosan short fiber and wherein sodium ion and calcium ion weight ratio be 10: 90-30: 70 alginate short fiber mixes after carding, the pre-needled non-woven cloth of chitosan-alginate composite fibre that lapping and pre-pin are perverse is as bottom, with wherein sodium ion and calcium ion weight ratio is 10: 90-30: 70 alginate short fiber or other hygroscopicity fibre are through carding, the single alginate that lapping and pre-pin are perverse or the pre-needled non-woven cloth of other hygroscopicity fibre are as the two-layer compound pin needled non-woven cloth dressing on upper strata.
6, according to the described medical non-woven cloth with organism function dressing procucts of claim 5, it is characterized in that: in the prefabricated non-woven fabrics of chitosan-alginate composite fibre, the mixed proportion of chitosan short fiber and alginate short fiber is: the chitosan short fiber accounts for the 5-100% of chitosan short fiber and alginate short fiber gross weight.
7, according to the described medical non-woven cloth with organism function dressing procucts of claim 5, it is characterized in that: as other hygroscopicity fibre in the pre-needled non-woven cloth of other hygroscopicity fibre on upper strata is cotton fiber, vinylon fiber or viscose rayon.
8, according to each described living body function medical adhesive-bonded fabric dressing goods of claim 5-7, it is characterized in that: as the weight per unit area of the chitosan-pre-needled non-woven cloth of alginate composite fibre of bottom be the 20-200 gram/square metre; As the weight per unit area of the single alginate on upper strata or the pre-needled non-woven cloth of other hygroscopicity fibre be the 40-400 gram/square metre.
CN95108238A 1995-07-28 1995-07-28 Method for preparation of biofunctional medical adhesive-bonded fabric dressing and its products Expired - Fee Related CN1056087C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95108238A CN1056087C (en) 1995-07-28 1995-07-28 Method for preparation of biofunctional medical adhesive-bonded fabric dressing and its products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95108238A CN1056087C (en) 1995-07-28 1995-07-28 Method for preparation of biofunctional medical adhesive-bonded fabric dressing and its products

Publications (2)

Publication Number Publication Date
CN1119547A CN1119547A (en) 1996-04-03
CN1056087C true CN1056087C (en) 2000-09-06

Family

ID=5076704

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95108238A Expired - Fee Related CN1056087C (en) 1995-07-28 1995-07-28 Method for preparation of biofunctional medical adhesive-bonded fabric dressing and its products

Country Status (1)

Country Link
CN (1) CN1056087C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103110477B (en) * 2013-02-25 2014-03-26 苏州艾美医疗用品有限公司 Manufacturing method of composite medical non-woven fabric absorbent pads
CN106902380A (en) * 2017-03-15 2017-06-30 张太平 A kind of medical wet combine dressing

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071587A (en) * 1991-10-11 1993-05-05 青岛海洋大学 A kind of production technology of biological material sponge
CN1072595A (en) * 1991-11-26 1993-06-02 曹应龙 The production method of burn and scald gel

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1071587A (en) * 1991-10-11 1993-05-05 青岛海洋大学 A kind of production technology of biological material sponge
CN1072595A (en) * 1991-11-26 1993-06-02 曹应龙 The production method of burn and scald gel

Also Published As

Publication number Publication date
CN1119547A (en) 1996-04-03

Similar Documents

Publication Publication Date Title
EP2627813B1 (en) Hydrogel fibres and fibrous structures
KR102006836B1 (en) Method of preparation of polysaccharide fibers, wound covers that contain them, method of manufacturing of wound covers, and apparatus for preparation of polysaccharide fibers
JP5738754B2 (en) Wound dressing
US4651725A (en) Wound dressing
JPH08505790A (en) Trauma bandage
WO2012142879A1 (en) Wound dressing with bacteriostasis and hygroscopicity
CN107469131A (en) A kind of calcium alginate biology based composite dressing for medical use and preparation method thereof
WO2014101458A1 (en) Chemically modified sea silk fiber, wound dressing made therefrom and preparation method thereof
CN104958135A (en) Alginate blending gauze
CN87101823B (en) medical non-stick dressing
CN103126806A (en) High-wet-strength wound dressing
JPS5854059A (en) Production of alginic acid fiber material and product
CN104768584A (en) Absorbent materials
CN1940153A (en) Chitose graft alginate fibre, its production and use
CN1056087C (en) Method for preparation of biofunctional medical adhesive-bonded fabric dressing and its products
JPH0835193A (en) Method for producing non-woven collagen fiber sheet
CN202982403U (en) High humidity strength wound dressing
CN111991606B (en) Micro-nano alginate fiber dressing and preparation method thereof
JPH05209318A (en) Calcium alginate fiber having excellent liquid absorbing property and covering material for medical use
CN1030339C (en) Method for making absorbable hemostatic dressing
CN1068916C (en) Chitin fibers and production thereof
CN1065138C (en) Method for manufacture seaweed acid calcium medicated plaster and seaweed acid calcium fibre nonwoven fabrics
CN212369351U (en) Micro-nano alginate fiber composite polypropylene melt-blown fabric dressing
CN1470679A (en) Chitin nonwoven fabric and production method thereof
EP3074568B1 (en) Hydrogelling fibers and fiber structures

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee